- Tytuł :
- Real-world survival outcomes of adding docetaxel or abiraterone in patients with high-volume metastatic castration-sensitive prostate cancer: historically controlled, propensity score matched comparison with androgen deprivation therapy.
- Autorzy :
- Źródło :
-
World Journal of Urology . May2022, Vol. 40 Issue 5, p1135-1141. 7p. -
Czasopismo naukowe